Navigation Links
Virogen Announces Launch of New Business Unit, "The Cannabis Connection", and Sets Sights on $15-20 Billion Legal Marijuana Market
Date:5/2/2013

SAN GERONIMO, Calif., May 2, 2013 /PRNewswire/ -- Virogen Inc. (OTC:VRNI), a holding company with specialties in data security and encryption technology, today announced the launch of its newest business unit, "The Cannabis Connection", which is intended to operate medicinal marijuana dispensaries in states that have legalized such operations, including California.

With an estimated current annual value of approximately $120 billion (legal and illegal) and expected continued easing of marijuana laws nationwide, the marijuana market appears to be headed for a period of dramatic growth.  In California, The Cannabis Connection's home state, which represents approximately 10% of the overall U.S. market, 95%, or approximately $11 billion, of marijuana sales are made legally through medicinal marijuana dispensaries. The company's management has equated the current state of the legal marijuana industry to the post-prohibition U.S. alcohol industry, in terms of the massive consumer market, volume of consumption, market fragmentation and opportunity for profit.

It is the fragmented nature of the legal marijuana market that provides the greatest source of optimism for the company's management. This highly fragmented market is dominated by independent operators, many of whom were "dealers" prior to the legalization of marijuana, who invested minimal capital and operate their marijuana outlets in areas where overhead is low. It is the market fragmentation coupled with the relative lack of sophistication of existing operators that provide the company with its opportunity to consolidate existing outlets and operate a chain of dispensaries, all within an extremely short timeframe.

About Virogen, Inc.

In addition to developing its recently announced business unit, The Cannabis Connection, Virogen, Inc. is a technology holding company. The company's wholly owned subsidiary, Tiger Team Technologies "T3," has developed a very unique suite of copyrighted tools to address the network and database security needs of enterprise level companies and corporations. T3's risk management offering provides an unprecedented level of security and liability protection, positioning it as one of the only companies with a comprehensive solution to data security breaches for its clients. T3's primary markets include medical service providers, financial services firms, brokerages and currency transaction platforms, consumer credit card companies, banking entities, retailers, defense and government related operations.

Forward-Looking Statements:

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Virogen, Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions the occurrence of unanticipated events or changes to future operating results.

Contact: Paul Hogan , paul@tigerteamtech.com, 415-488-6214


'/>"/>
SOURCE Virogen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardium Announces Generx Publication In Molecular Therapy
2. Medifirst Solutions, Inc. Announces New Healthcare And Wellness Division
3. Ferring Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologists Annual Clinical Meeting
4. Abide Therapeutics Announces Collaboration With Merck to Develop Novel Therapies for Type 2 Diabetes and Metabolic Diseases
5. BD Announces Results For 2013 Second Fiscal Quarter
6. Sofinnova Ventures Announces Team Expansion and Promotion
7. PharmaRoth Labs, Inc. Announces Trading Symbol Change
8. Paratek Pharmaceuticals Announces Expanded FDA Grant of Qualified Infectious Disease Product (QIDP) Designation for Its Lead Product Candidate, Omadacycline
9. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
10. GW Pharmaceuticals Announces Pricing of Initial Public Offering on the NASDAQ Global Market
11. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016   Click here ... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent ... a definitive agreement to acquire Valley Campus Pharmacy, ... ("TNH"), a leading specialty pharmacy that provides individualized ... California . In 2015, TNH generated approximately ...
(Date:4/28/2016)... April 28, 2016  The blood testing market in ... according to Kalorama Information and The Freedonia Group in ... nucleic acid testing.  The healthcare research firm said that ... developing blood collection stations and in improving testing at ... Information,s report, Blood Testing Market in China ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification Program ... to announce the launch of the GFCP Scoop in response to ... purpose of the GFCP Scoop site is to keep the gluten-free ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... Cosmetic dentistry is a fast-growing field as more patients are discovering the many different ... more about the options currently available to them and which ones might work for ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Reltok Nasal Products ... products for the head and neck/ear, nose and throat specialty, has added the KOTLER ... The KOTLER NASAL AIRWAY™ is a newly patented safety device secured by nasal ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, ... round of funding led by Eastside Partners, with participation from existing investor Martin ... customer base and accelerate its technology and product roadmap. , “Jvion ...
(Date:4/29/2016)... ... 2016 , ... Regenerative Medicine Solutions (RMS) scored 94.8124 out of ... them second place for Tampa’s Best Places to Work. They were ranked in the ... great accomplishment for our team,” says RMS Human Resources Manager Irene Miller. “We work ...
Breaking Medicine News(10 mins):